Hurry up and slow down: lessons in drug development from the COX-2 inhibitors.
Stafford-Smith
Mark
M
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans
D052246:Cyclooxygenase 2 Inhibitors